<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Concessional SGST Rates on Specified COVID-19 Medicines (2021)</title>
    <link>https://www.taxtmi.com/notifications?id=146965</link>
    <description>Goa grants a time-bound concessional State tax exemption for specified COVID-19 medicines classified under Chapter 30. State tax is nil for Tocilizumab and Amphotericin B, while a concessional rate of 2.5% applies to Remdesivir, Heparin, Itolizumab, Posaconazole, Infliximab, Bamlanivimab and Etesevimab, Casirivimab and Imdevimab, 2-Deoxy-D-Glucose, and Favipiravir. The concessional treatment operates from 1 October 2021 through 31 December 2021, inclusive.</description>
    <language>en-us</language>
    <pubDate>Thu, 30 Sep 2021 00:00:00 +0530</pubDate>
    <lastBuildDate>Thu, 17 Sep 2026 12:32:52 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=923816" rel="self" type="application/rss+xml"/>
    <item>
      <title>Concessional SGST Rates on Specified COVID-19 Medicines (2021)</title>
      <link>https://www.taxtmi.com/notifications?id=146965</link>
      <description>Goa grants a time-bound concessional State tax exemption for specified COVID-19 medicines classified under Chapter 30. State tax is nil for Tocilizumab and Amphotericin B, while a concessional rate of 2.5% applies to Remdesivir, Heparin, Itolizumab, Posaconazole, Infliximab, Bamlanivimab and Etesevimab, Casirivimab and Imdevimab, 2-Deoxy-D-Glucose, and Favipiravir. The concessional treatment operates from 1 October 2021 through 31 December 2021, inclusive.</description>
      <category>Notifications</category>
      <law>GST - States</law>
      <pubDate>Thu, 30 Sep 2021 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/notifications?id=146965</guid>
    </item>
  </channel>
</rss>